Northern Star Resources announced the appointment of Suresh Vadnagra as its new Managing Director and CEO. Following the announcement, the company's share price closed down at $18.80. The leadership ...

Hims & Hers (NYSE:HIMS) posted first-quarter revenue of $608.1 million, a 4% increase compared to $586 million in the prior-year period. However, the company’s gross margin fell to 65% from 73% a year ...

Australian retail giant Sigma Healthcare (ASX:SIG) announced its foray into the United Kingdom, securing a majority stake in the London-based Greenlight Healthcare chain. The strategic acquisition ...

IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...

Texas Instruments (NASDAQ:TXN) reported its financial results for the first quarter of 2026, signaling a significant recovery in the semiconductor sector. The Dallas-based chipmaker achieved revenue ...

Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...

Oracle (NYSE:ORCL) delivered third-quarter fiscal 2026 results on Tuesday that exceeded Wall Street expectations, bolstered by a massive wave of demand for its artificial intelligence (AI) cloud ...

Incyte (NASDAQ:INCY) announced today that it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for an upfront payment of $1.25 ...

UnitedHealth Group (NYSE:UNH) today reported financial results for the first quarter of 2026, delivering growth across its primary business platforms and raising its full-year earnings outlook. The ...

A Los Angeles County Superior Court jury has ordered Johnson & Johnson (NYSE:JNJ) to pay $32 million to the family of a California woman who died from pleural mesothelioma, concluding that her fatal ...

AbbVie (NYSE:ABBV) delivered a robust full-year performance for 2025, proving that its strategy to replace the aging blockbuster Humira is ahead of schedule as its newer immunology and neuroscience ...

Island Pharmaceuticals (ASX:ILA) formalised a three-year cooperative research and development agreement with the United States Army Medical Research Institute of Infectious Diseases and The Geneva ...